Consultation outcome

Distributing vaccines and treatments for COVID-19 and flu

This consultation has concluded

Download the full outcome

Detail of outcome

The government hosted a public consultation from 28 August to 18 September on changes to the Human Medicines Regulations to support the rollout of COVID-19 vaccines. This is the formal government response to that consultation.

Original consultation


We want your views on proposed changes to the Human Medicine Regulations to help with the safe and efficient distribution of a COVID-19 vaccine and expanded flu vaccine programme in the UK, along with treatments for COVID-19 and any other diseases that become pandemic.

This consultation ran from

Consultation description

The UK government, with the Minister of Health in Northern Ireland, is seeking views on proposed changes to the Human Medicine Regulations 2012.

The consultation covers:

  • authorising temporary supply of an unlicensed product
  • civil liability and immunity
  • expanding the workforce eligible to administer vaccinations
  • promoting vaccines
  • making provisions for wholesale dealing of vaccines


Published 28 August 2020
Last updated 5 August 2021 + show all updates
  1. In the consultation response, amended point 1 under 'Summary of changes' and the call-out box for 'Change 1' (under 'Attaching conditions to a temporarily authorised vaccine') to refer to regulation 174A (not 174). The impact of regulation 174A will be formally reviewed as soon as practicable after a year of any first use.

  2. Added the final outcome document.

  3. First published.